LuTran
Ronald Griffith is a highly experienced professional in the biotechnology and pharmaceutical sectors, currently serving as the Director and Chief Science Officer at LuTran Inc. since April 2014. Additionally, Ronald operates as a Principal at RG Pharmaceutical Consulting, focusing on drug discovery, medicinal chemistry, DMPK, and preclinical development for various companies. Prior experience includes roles as Chief Scientific Officer and VP of Research at Genelabs Technologies from 2001 to 2010, VP of Chemistry at Tanabe Seiyaku Co LTD from 1997 to 2000, and Executive Director of Chemistry at AstraZeneca from 1974 to 1997. Ronald holds a Ph.D. in Organic Chemistry from Syracuse University and has completed a postdoctoral research fellowship at Caltech.
This person is not in any teams
This person is not in any offices
LuTran
OUR DEVELOPMENT, PASSION AND UNWAVERING COMMITMENT IN THE FIGHT AGAINST VIRAL AND ALZHEIMER’S DISEASELuTran Inc. is a dynamic, innovation–driven pharmaceutical research company located in the heart of Silicon Valley, where we push the boundaries of medical science to discover and develop novel medicines for some of the world's mostdebilitating viral and neurological diseases: from AIDS through biosafety level 4 viruses, including Ebola hemorrhagic fever and Alzheimer’s.OUR MISSION STATEMENT IS OUR CONSTITUTION, VISION AND VALUESOur mission is to develop novel, more effective medicines through scientific innovation, to ultimately live in a world where humankind regardless of their geographic region or social status, can live free from infectious viral diseases and Alzheimer’s.CONTINUOUS TRANSFORMATION IS KEY TO OUR INNOVATIVE RESEARCHOur innovation is the result of our passion, commitment and pushing the limits of our understanding by exploring new ideas to accelerate the discovery, development and delivery of next–generation medications. We celebrate curiosity and encourage our researchers to take chances in discovering novel solutions to increase longevity and improve quality of life for millions of people around the world.STAYING COMMITTED TO OUR DISCOVERIES WITH ONGOING FLEXIBILITY IN FINDING NOVEL SOLUTIONSInnovation doesn't just stop with the development of new technologies or creating a new kind of compound. We believe scientific innovation, especially in the medical field, should be linked with the human experience. Therefore, any new idea, any innovation needs to be developed and utilized in a way with a positive impact on the lives of patients around the globe.